Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium

Oncogene

Volumn 12, Issue 6, 1996, Pages 1247-1257

  Neyns, B ^a   Katesuwanasing, D ^a   Vermeij, J ^a   Bourgain, C ^a   Vandamme, B ^a   Amfo, K ^a   Lissens, W ^a   De Sutter, P ^a   Hooghe Peters, E ^b   De Greve J ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

c jun; jun B; jun D; Normal ovarian surface epithelium; Ovarian cancer; Proto oncogene

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE C JUN; OVARY; OVARY CANCER; PRIORITY JOURNAL; SERUM;

3T3 CELLS; ANIMALS; BLOTTING, NORTHERN; EPITHELIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, JUN; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; OVARIAN NEOPLASMS; OVARY; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-JUN; REFERENCE VALUES; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 9244226475     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Allum WH, Newbold KM, Macdonald F, Russell B and Stokes H. (1987). Br. J. Cancer, 56, 785-786.
2. Amfo K, Neyns B, Teugels E, Lissens W, Bourgain C, De Sutter P, Vandamme B, Vamos E and De Grève J. (1995). Oncogene, 11, 351-358.
3. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T and Karin M. (1988). Nature, 332, 166-171.
4. Angel P and Karin K. (1991). Biochim. Biophys. Acta, 1072, 129-157.
5. Ausubel FM (ed). (1989). Current protocols in molecular biology. Greene publishing associates inc. and John Willey & Sons, inc.
6. Auwerx J and Sassone-Corsi P. (1992). Oncogene, 7, 2271-2280.
7. Auersperg A, Maines-Bandiera SL and Kruk PA. (1994). Ovarian Cancer III, Chapman & Hall Med. Publ. London.
8. Bauknecht T, Angel P, Kohler M, Kommoss F, Birmelin G, Pfleiderer A and Wagner E. (1993). Cancer, 71, 419-429.
9. Benham FJ, Hodgskinson S and Davies KE. (1984). EMBO, 3, 2635-2640.
10. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks S, McKenzie S, Yin S and Bast RC. (1990). Cancer Research, 50, 4087-4091.
11. Berchuck A, Kohler MF and Bast RC. (1992). Hematol. Oncol. Clin. North Am., 6, 813-827.
12. Berger I and Shaul Y. (1991). Oncogene, 6, 561-566.
13. Bigsby RM and Li A. (1994). Endocrinology, 134, 1820-1825.
14. Bossy-Wetzel E, Bravo R and Hanahan D. (1992). Genes Dev., 6, 2340-2351.
15. Carter R, Yumet G, Pena A, Soprano DR and Soprano KJ. (1994). Oncogene, 9, 2675-2682.
16. Castellazzi M, Spyrou G, La Vista N, Dangy JP, Piu F, Yaniv M and Brun G. (1991). Proc. Natl. Acad. Sci. USA, 88, 8890-8894.
17. Chatton B, Bocco JL, Goetz J, Gaire M, Lutz Y and Kedinger C. (1994). Oncogene, 9, 375-385.
18. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN and Testa JR. (1992). Proc. Natl. Acad. Sci. USA, 89, 9267-9271.
19. Cohen DR, Vandermark SE, McGovern JD and Bradley MP. (1993). Oncogene, 8, 443-455.
20. de Groot RP and Sassone-Corsi P. (1992). Oncogene, 7, 2281-2286.
21. De Grève J, Vandamme B, Lissens W, Bourgain C, Liebaers I and Bernheim J. (1990). Proceedings American Association Cancer Research, 31, 131. (Abstract).
22. Heurteaux C, Bertaina V, Widmann C and Lazdunski M. (1993). Proc. Natl. Acad. Sci. USA, 90, 9431-9435.
23. Hirai S-I, Rysec RP, Mechta F, Bravo R and Yaniv M. (1989). EMBO, 8, 1433-1439.
24. Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K and Miwa M. (1994). Cancer Research, 54, 33-35.
25. Jones DJ, Gosh AK, Moore M and Schofield PF. (1987). Br. J. Cancer, 56, 779-783.
26. Kameda K, Akahori A, Sonobe MH, Suzuki T, Rendo T and Iba H. (1993). Proc. Natl. Acad. Sci. USA, 90, 9369-9373.
27. Kerppola T and Curran T. (1994). Oncogene, 9, 675-684.
28. Khan I, Hossain A, Whitman GF, Sarkar NH and McDonough P. (1993). Prostaglandins, 46, 139-144.
29. Koo SA, Chiu R, Soong J, Dekernion JB and Belldegrun A. (1992). The J. of Urology, 148, 1314-1318.
30. Kovary K and Bravo R. (1991). Mol. Cell Biol., 11, 2451-2459.
31. Kruk PA, Maines-Boudiera SL and Auersperg N. (1990). Lab. Invest., 63, 132-136.
32. Magrisso IJ, Richmond RE, Carter JH, Pross CB, Gilfillen RA and Carter HW. (1993). Lab. Invest., 6, 674-681.
33. Marti A, Jehn B, Costello E, Keon N, Ke G and Martin F. (1994). Oncogene, 9, 1213-1223.
34. Mattei MG, Simon-Chazottes D, Hirai S, Ryseck RP, Galcheva-Gargova Z, Guenet JL, Mattei JF, Bravo R and Yaniv M. (1990). Oncogene, 5, 151-156.
35. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C and Frank TS. (1995). Nature Genetics, 9, 439-443.
36. Milner BJ, Allan LA, Eccles DM, Kitchener HC, Leonard RC, Kelly KF, Parkin DE and Haites NE. (1993). Cancer Research, 53, 2128-2132.
37. Monteclaro FP and Vogt P. (1993). Proc. Natl. Acad. Sci. USA, 90, 6726-6730.
38. Motta P, Van Blerkom J and Makabe S. (1980). J. Submicrosc. Cytol., 12, 407-425.
39. Nephew KP, Polek TC, Akcali KC and Kahn SA. (1993). Endocrinology, 133, 419-422.
40. Nomura N, Ide M, Sasamoto S, Matsui M, Date T and Ishizaki R. (1990). Nucl. Acids Res., 18, 3047-3048.
41. Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M and Yokota J. (1991). Cancer Research, 51, 5171-5176.
42. Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S and Yaniv M. (1994). Cell, 76, 747-760.
43. Rubin SC, Finstad CL, Federici MG, Scheiner L, Lloyd KO and Hoskins WJ. (1994). Cancer, 73, 1456-1459.
44. Ryder K, Lanahan A, Perez-Albuerne E and Nathan D. (1989). Proc. Natl. Acad. Sci. USA, 86, 1500-1503.
45. Schlingensiepen KH, Schlingensiepen R, Kunst M, Klinger I, Gerdes W, Seifert W and Brysch W. (1993). Dev-Genet, 14, 305-312.
46. Schütte J, Viallet J, Nau M, Shoshana S, Fedorko J and Minna J. (1989). Cell, 59, 987-997.
47. Siemens CH and Auersperg N. (1988). J. Cell Physiol., 134, 347-356.
48. Singleton TP, Perrone T, Oakley G, Niehans GA, Carson L, Cha SS and Strickler JG. (1994). Cancer, 73, 1460-1466.
49. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press FP. (1989). Science, 244, 707-712.
50. Smith MJ and Prochownik VE. (1992). Blood, 79, 2107-2115.
51. Stewart J, Evan G, Watson J and Sikora K. (1986). Br. J. Cancer, 53, 1-4.
52. Tashiro H, Miyazaki K, Okamura H, Iwai A and Fukumoto M. (1992). Int. J. Cancer, 50, 828-833.
53. Tsao SW, Mok CH, Oike K, Muto M, Goodman HM, Sheets EE, Berkowitz RS, Knapp RC and Lau CC. (1991). Anticancer research, 11, 1975-1982.
54. Tyson FL, Boyer CM, Kaufman R, O'Briant K, Cram G, Crews JR, Soper JT, Daly L, Fowler WC Jr and Haskill JS. (1991). Am. J. Obstet. Gynecol., 165, 640-646.
55. Vandamme B, Lissens W, Amfo K, De Sutter P, Bourgain C, Vamos E and De Greve J. (1992). Cancer Research, 52, 6646-6652.
56. Yamaguchi Y, Satake M, Murakami Y, Sakai M, Muramatsu M and Ito Y. (1990). Proc. Natl. Acad. Sci. USA, 87, 8670-8674.
57. Yamit-Hezi A, Plaksin D and Eisenbach L. (1994). Oncogene, 9, 1065-1079.
58. Young RC, Perez CA and Hoskins WJ. Cancer of the Ovary. In: Cancer, Principles & Practice of Oncology, edited by DeVita VTJr, Hellman S and Rosenberg SA. Philadelphia: J.B. Lippincott Companys, 1993, p. 1226-1264.